My friend Dana started tirzepatide last October. She’s a good home cook, the kind of person who keeps homemade stock in the freezer and actually uses her mandoline. Two weeks in, she called me almost panicked: “I made my normal Sunday roast chicken dinner and took three bites and felt like I’d eaten Thanksgiving. What do I even cook now?” That conversation, and a dozen like it since, is why this piece exists. When your appetite shrinks by half or more, the question isn’t really “what diet should I follow?” It’s “how do I get enough nutrition from a fraction of the food I used to eat?”
In short, prioritize protein at 1.2 to 1.6 g/kg body weight daily, choose lean and easily digested foods (especially early in titration), drink 75 to 100 ounces of water, and pull back on fried or very sweet foods that amplify nausea. Smaller portions happen on their own because of slowed gastric emptying. Food quality is what you actually control.
Why Eating on GLP-1 Therapy Requires a Different Playbook
Tirzepatide is a dual GIP and GLP-1 receptor agonist, administered once weekly by subcutaneous injection. It activates two gut peptide pathways involved in glucose regulation, appetite, and gastric emptying. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported mean weight reductions of 15.0% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg over 72 weeks in adults with obesity. Those are population averages; individual responses ranged widely.
What matters for the kitchen is the gastric emptying piece. Both tirzepatide and semaglutide slow the rate at which your stomach empties through GLP-1 receptor activation in the brainstem and vagal afferents. Food sits longer. You feel full faster and stay full longer. That’s the mechanism behind reduced appetite, and it’s also why a plate of fried mozzarella sticks that used to be a Friday indulgence can now leave you nauseated for hours.
Compounded tirzepatide preparations use the same active pharmaceutical ingredient. The mechanism is identical. The differences are in manufacturing oversight, regulatory framework, and supply chain.
The practical upshot: your total caloric intake drops, sometimes dramatically. If you don’t deliberately choose nutrient-dense foods, you can end up protein-deficient, dehydrated, and tired while the scale looks great. That’s a bad trade.
The Protein Problem (and How to Solve It)
Protein adequacy is the single most important nutritional priority on GLP-1 therapy. Aim for 1.2 to 1.6 grams per kilogram of body weight per day, spread across three to four meals. For a 180-pound person, that’s roughly 100 to 130 grams daily.
That number is harder to hit than it sounds when your appetite has cratered. Three bites of chicken at dinner is maybe 10 grams. You have to be strategic.
Foods that tend to sit well, especially during the first weeks:
- Eggs. Versatile, cheap, easy to digest. Two eggs give you about 12 grams.
- Greek yogurt and cottage cheese. High protein density per volume. A cup of Greek yogurt is 15 to 20 grams depending on brand.
- Fish. White fish especially. Light, easy to tolerate.
- Chicken breast. The boring workhorse. Works.
- Tofu. Surprisingly well tolerated even during nausea windows.
- Protein shakes. Sometimes the only realistic option at breakfast during early titration. Watch added sugars.
Fattier proteins (ribeye, pork belly, lamb shoulder) can amplify nausea during titration. Save those for when you’re stable on dose.
Produce density matters more now because total intake has fallen. You’re getting fewer bites per day, so each bite needs to carry more micronutrients. Cooked vegetables tend to be better tolerated than raw during the first months. A bowl of steamed broccoli with a squeeze of lemon goes down easier than a raw kale salad.
Fluids: 75 to 100 ounces daily is a working target. Many people underestimate how much fluid they were getting from food before their portions shrank. Electrolyte supplementation during the first weeks reduces lightheadedness complaints noticeably.
What to moderate or skip during titration: fried foods, high-fat meals, very sweet foods, carbonated beverages, and alcohol. These are the most common nausea amplifiers across patient populations.
A Realistic Day of Eating
Think of this less as a meal plan and more as a template for the math to work:
Breakfast: Greek yogurt with berries and chia seeds. Gets you 20 to 25 grams of protein before you’ve really thought about food. Well tolerated even on nausea-heavy mornings.
Lunch: Tuna or chicken salad with mixed greens, olive oil, lemon, and a small serving of whole grain or beans. Protein-forward and digestible. If you’re not hungry enough for a full salad, even half this portion moves you in the right direction.
Dinner: Lean protein (chicken, fish, tofu) with cooked vegetables and a small portion of starch. This is where Dana landed after her roast chicken crisis: smaller pieces, more vegetables, less of the starchy sides she used to load up on.
Snack: Cottage cheese with berries, a hard-boiled egg, or a protein shake. Fills the gap to hit daily protein targets without requiring another full meal.
Beverages: Water with electrolytes, especially in hot weather or after exercise. Skip carbonated drinks if you’re nausea-prone.
Side Effects, Safety, and When to Worry
Gastrointestinal symptoms dominate the side effect profile. Nausea hits 30 to 45% of patients in trial populations. Diarrhea, constipation, and vomiting follow behind. Most of this concentrates in the first 4 to 8 weeks and around dose escalations. Severity typically peaks shortly after a step-up and attenuates over 2 to 3 weeks at a stable dose.
| Symptom | Reported frequency | Typical timing | Management | |—|—|—|—| | Nausea | 30 to 45% | First 4 to 8 weeks, worse with dose increases | Smaller meals, lower fat, water sipping, antiemetic if persistent | | Diarrhea | 15 to 23% | Variable | Hydration, electrolyte review, BRAT-style meals briefly | | Constipation | 10 to 17% | Often after GI slowing sets in | Fiber 25 to 35 g daily, hydration, magnesium if cleared by clinician | | Vomiting | 8 to 13% | First weeks; escalations | Hold dose, consult prescriber if persistent | | Reflux | 7 to 12% (often underreported) | Throughout therapy | Avoid eating within 3 hours of bedtime, raise head of bed | | Fatigue | Variable | First weeks | Usually self-resolves; check ferritin, B12, thyroid if persistent |
More serious labeled risks include pancreatitis, gallbladder disease, severe hypoglycemia (particularly combined with insulin or sulfonylureas), kidney injury from severe dehydration, and a boxed warning for medullary thyroid carcinoma based on rodent studies.
Baseline labs worth requesting before starting: comprehensive metabolic panel (CMP), HbA1c and fasting glucose, lipid panel, TSH, lipase if there’s any personal history of pancreatitis, and CBC. Repeat at 12 to 16 weeks, then roughly every 6 months once stable. Severe abdominal pain radiating to the back warrants immediate clinician contact to rule out pancreatitis.
Dosing: What to Expect at Each Step
Standard tirzepatide dosing starts at 2.5 mg weekly for four weeks. This is the tolerance phase, not the therapeutic phase. Don’t expect much weight loss here.
The jump to 5 mg for the next four weeks is where most people notice real appetite reduction. Subsequent steps to 7.5, 10, 12.5, and 15 mg happen at four-week intervals based on tolerance and response. Maximum FDA-labeled dose for chronic weight management is 15 mg.
Here’s a point I think gets underemphasized: not everyone needs 15 mg. Many patients stabilize at 5 to 10 mg once they reach their goal, balancing ongoing benefit against side effects and cost. Compounded preparations sometimes allow intermediate doses like 6.25 or 8.75 mg that aren’t available in branded autoinjectors, which gives prescribers more room to fine-tune when someone is between steps.
| Phase | Typical dose | Duration | Notes | |—|—|—|—| | Initiation | 2.5 mg weekly | Weeks 1 to 4 | GI tolerance, not weight loss | | Step 1 | 5 mg weekly | Weeks 5 to 8 | First meaningful weight loss expected | | Step 2 | 7.5 mg weekly | Weeks 9 to 12 | Some protocols hold here if response is adequate | | Step 3 | 10 mg weekly | Weeks 13 to 16 | Common long-term maintenance tier | | Step 4 | 12.5 mg weekly | Weeks 17 to 20 | Reserved for attenuating response | | Step 5 | 15 mg weekly | Week 21+ | Maximum labeled dose; not universal |
For deeper clinical reference on dosing, monitoring, and regulatory context organized for patients comparing options, see https://formblends.com/articles/lifestyle-hub/glp1-diet-food-guide.
When to Talk to a Clinician
Before starting therapy, get a clinical evaluation if you have: personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, severe gastroparesis, severe hepatic impairment, current pregnancy or active pregnancy planning, or current use of insulin or sulfonylureas without diabetes management oversight.
During therapy, contact your prescriber for: severe persistent abdominal pain (especially radiating to the back), signs of dehydration from vomiting or diarrhea, vision changes (particularly in diabetic patients), severe persistent reflux, signs of allergic reaction, or any symptom that feels markedly outside normal titration experience.
Routine clinical contact every 12 to 16 weeks during active titration and every 6 months once stable is reasonable. Labs should follow the same schedule.
Frequently Asked Questions
What foods are easiest on the stomach?
Lean protein (chicken, fish, tofu, Greek yogurt), low-FODMAP produce, plain carbohydrates like rice and oats, and bland soups during nausea spikes.
What foods trigger nausea most often?
Greasy, fried, very sweet, and carbonated foods top the list. Large portions worsen symptoms regardless of food type.
How much protein should I aim for?
1.2 to 1.6 grams per kilogram body weight daily during active weight loss to preserve lean mass. Spread across 3 to 4 meals for better utilization.
Are smoothies or shakes okay?
Yes, and often a lifesaver for meeting protein targets when appetite is nonexistent. Watch added sugars and prioritize complete protein sources.
Should I count calories?
Most patients find it unnecessary because intake drops naturally. Tracking protein and produce intake is usually more useful than calorie precision.
What about hydration?
75 to 100 ounces of fluid daily is a practical target. Add electrolytes during the first weeks, especially if you’re experiencing lightheadedness.
Can I drink alcohol on GLP-1 therapy?
It’s not strictly prohibited, but alcohol tends to amplify nausea and dehydration, both of which are already concerns during titration. Many patients find their tolerance drops significantly. If you drink, go slowly and stay hydrated.
Important regulatory note. Compounded tirzepatide is not FDA-approved. It is prepared by licensed 503A or 503B pharmacies for individual patients based on a prescriber’s clinical judgment. Compounded preparations are not evaluated by the FDA for safety, efficacy, or quality the way branded products are. Research suggests outcomes vary between patients, and any decision to begin, modify, or discontinue therapy should occur in coordination with a licensed clinician who can review your medical history, current medications, and laboratory values.
